A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.


Updates from The Motley Fool

Latest updates on Celsion from Fool.com.
3 Biotech Stocks To Avoid

After a history of failures, these three biotech stocks are running out of ideas and cash to keep...

A Fool Looks Back

A lot of things happened this past week. Let's check it out.

The Fool Looks Ahead

It will be an interesting week if you know where to look.

This Week in Biotech

A look back at the biggest stories this week in biotech and what they mean for investors.

This Week in Biotech: Part 1

A look back at the biggest stories this week in biotech and what they mean for investors.

New Hope for Celsion Investors?

This agreement adds more suspense as investors await Phase 3 clinical trial results from Celsion.

3 Biotechs Burning Through Cash

Investors would be wise to know how biotech companies are spending that cash on hand while they d...



Stock Performance

View Interactive CLSN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Celsion.
Current Price: $0.27
Prev Close: $0.27
Open: $0.26
Bid: $0.26
Ask: $0.27
Day's Range: $0.26 - $0.27
52wk Range: $0.18 - $1.78
Volume: 303,095
Avg Vol 4,137,723
Market Cap: $14M
P/E (ttm): -0.32
EPS (ttm): ($0.90)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Celsion.
CAPS Rating 1 out of 5
 
78 Outperform
15 Underperform
CAPS All Stars
 
5 Outperform
6 Underperform

How do you think Celsion will perform against the market?



You pick for Celsion is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael H. Tardugno, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Celsion.

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers